Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. King-Jones Heidy −$5.1M See Remarks sold 95% of stake
  2. Burrows Scott L −$4.5M Chief Financial Officer sold 39% of stake
  3. Turtle Cameron −$2.7M Chief Executive Officer sold 5% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion · Series A Preferred Stock −890,476 0
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion · Series B Preferred Stock −1,120,448 0

Page 12 of 12 · 222 trades